BioSpace News Archive

The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19.

ReviveMed is proud to announce that they are pursuing an evaluation study with Bristol Myers Squibb (NYSE: BMY). This study will leverage ReviveMed’s artificial intelligence (AI) platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. “We are very excited about this opportunity to work alongside industry leaders on the Bristol Myers Squibb team,” said Dr. Leila

Intralink-Spine, Inc. (ILS) announces the expansion of clinical trials for their patented injectable medical device, Réjuve ®, intended in Australia for the treatment of low back pain. “We’re pleased that Dr. Yu and Dr. Green have joined Dr. Rosenberg to participate in the GEM-SE clinical study for low back pain,” says Lyle Hawkins, CEO of Intralink-Spine, Inc. “Low back pain due to degenerative disc disease is v

IntraOp Medical Corporation announced today the delivery of its pre-clinical high dose rate electron beam linear accelerator to The Ohio State University Comprehensive James Cancer Center

eDNA, defined as any trace or fragment of DNA released from an organism into the environment, is proving to be an attractive tool in exploring and studying Earth’s biodiversity due to its noninvasive approach and relatively lower cost for sample collection and species monitoring.

IBH Population Health Solutions (Integrated Behavioral Health, Inc.), a national leader in behavioral health technology and services, announced the launch of its new Provider Clinical Data Analytics technology platform that uses artificial intelligence (AI) and machine learning to improve the quality and outcomes of talk therapy counseling.

Deep Longevity, a biotechnology company transforming longevity R&D through AI-discovered biomarkers of aging, came out of stealth today from Insilico Medicine with financing from prominent investors worldwide, the launch of the first AI system on the market for aging-related biomarker development, and collaboration with Human Longevity Inc.

Integral Molecular has launched an expanded panel of SARS-CoV-2 Reporter Virus Particles (RVP), which includes spike protein variants such as D614G and spike protein from other related coronaviruses.

In an effort to provide accurate and easily accessible information about the ongoing COVID-19 pandemic, the Multiple Sclerosis Association of America (MSAA) and Wondros are proud to announce the creation of the COVID-19 and MS Pathfinder online tool, available on MSAA’s website at https://mymsaa.org/covid-19-and-ms-pathfinder/.

The special supplement examines strategies, best practices and technologies to make dentistry as safe as possible for clinicians and patients in the COVID-19 health care environment